Search results
Found 34 matches for
Mathematician boosts data science research at the Kennedy Institute
Department
19 October 2022
Welcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.
NIHR funding for musculoskeletal and inflammatory disease research
Department Funding
17 October 2022
Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.
Leducq Foundation grant boosts cardiovascular research
Department Funding
11 October 2022
The Leducq Foundation has awarded $7.5 million to researchers at the University of Oxford and their collaborators to advance immunotherapy as a treatment for cardiovascular disease, the leading cause of death in the UK.
Welcome to the new Kennedy Trust CEO
Department
12 July 2022
The Kennedy Trust has announced Dr Stephen Simpson as its new Chief Executive Officer from 1 July 2022.
Breakthrough in treatment for Dupuytren’s disease
Department
30 April 2022
Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.
Professor Chris Buckley joins the Kennedy Institute as Director of Clinical Research
Department
12 January 2022
Moving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.
New Oxford-Zeiss Centre of Excellence opens at the University of Oxford
Department General
17 December 2021
The Kennedy Institute for Rheumatology and the Institute of Developmental and Regenerative Medicine announce the launch of the Oxford-Zeiss Centre of Excellence, providing state-of-the-art imaging technologies to lead future discoveries in global health and disease.
The Kennedy Institute scoops sustainability award
Awards Department
2 December 2021
A new roof extension was awarded the 2021 Green Award for Sustainability by the Oxford Preservation Trust alongside a Certificate in the New Building category.
Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors
Department
23 November 2021
Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.
The Kennedy Institute Student Symposium returns for its 5th year
Department General
30 September 2021
A two-day student symposium returned to the Kennedy Institute bringing together students and peers from across the department to discuss their latest research.
The Kennedy Institute completes its roof extension
Department General
17 August 2021
Building work at the Kennedy Institute of Rheumatology has finished, providing a new third floor that houses additional meeting and collaboration space for data science and offices for the management of clinical trials.
EPSRC funds research to avert an antibiotics apocalypse
Department Funding
7 June 2021
Researchers at the Kennedy Institute join a collaboration to find new ‘drug-free’ ways of treating illnesses where current treatments have become ineffective due to antibiotic resistance.
Professor Fiona Powrie elected to the National Academy of Sciences in the USA.
Department
29 April 2020
Fiona was recognised for her outstanding contributions to immunology, and her election brings the number of current National Academy of Sciences members from the Kennedy Institute to three.
Coronavirus information - what we are doing at NDORMS to support our staff and students and the community
Department
20 March 2020
NDORMS announces the closure of the Kennedy and Botnar Institutes and outlines other plans and activities for the department during the pandemic.
A workshop for curing arthritis sooner
Department
20 March 2018
Researchers from the Universities of Oxford and Birmingham joined forces with colleagues from seven NHS organisations at a workshop in Oxford to discuss an innovative new approach to inflammatory disease research.
Research challenges use of off-label drug to treat osteoarthritis
Department oacentre
21 February 2018
An off-label drug prescribed to treat osteoarthritis of the hand when conventional medication has failed is ineffective, according to new research.
2018 NDORMS Imaging Symposium and Awards
Awards Department
9 February 2018
The inaugural NDORMS Imaging Competition saw a fantastic collection of submissions of microscopic things which have a great impact in our bodies. The winners were announced at an Imaging Symposium held at the Kennedy Institute.
A secreted commensal sugar sweetens the deal for intestinal macrophages
Department Publication
20 December 2017
A recent publication from the Powrie group at the Kennedy Institute of Rheumatology has described a novel mechanism by which the commensal pathogen Heliobacter hepaticus maintains its niche in the intestinal environment.
ARUK award two Clinical Fellowships looking into Osteoarthritis of the Hand.
Department Funding oacentre
14 September 2017
Congratulations to our new ARUK Clinical Research Fellows, Dr Malvika Gulati and Miss Jennifer Lane on their successful Fellowship applications.
Professor Michael Dustin elected as EMBO member
Awards Department General
9 August 2017
Many congratulations to Professor Michael Dustin on his election as a member of the European Molecular Biology Organisation (EMBO).